Innovations in Therapeutic Strategies for Retinal and Neurodegenerative Diseases
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 25 July 2025 | Viewed by 818
Special Issue Editors
Interests: glaucoma; Alzheimer’s disease; neurodegeneration; neuroinflammation; neuroprotection; oxidative stress; mitochondrial dysfunction
Interests: glaucoma; Alzheimer’s disease; neurodegeneration; neuroinflammation; neuroprotection; oxidative stress; mitochondrial dysfunction
Special Issue Information
Dear Colleagues,
Neurodegenerative diseases, including glaucoma, Alzheimer’s disease, and retinal disorders such as age-related macular degeneration and diabetic retinopathy, represent a significant global health burden due to their progressive nature and lack of curative treatments. These conditions share common pathological mechanisms, including neuroinflammation, oxidative stress, and neuronal dysfunction, highlighting opportunities for innovative therapeutic approaches.
This Special Issue aims to provide a platform for groundbreaking research and translational advances in the treatment of retinal and neurodegenerative diseases. It seeks to highlight novel therapeutic strategies, ranging from gene and cell therapies to advanced drug delivery systems, as well as diagnostic approaches designed to detect early disease biomarkers and personalize treatments.
Potential topics include, but are not limited to, the following:
- Cellular and molecular mechanisms underlying retinal and neurodegenerative diseases;
- Novel therapeutic interventions, including gene therapy, neuroprotection, and regenerative medicine;
- Innovations in drug delivery platforms and biomaterials;
- Advances in retinal prostheses and bioengineered tissues for vision restoration;
- Neuroinflammation and oxidative stress as therapeutic targets;
- Artificial intelligence and imaging technologies for early diagnosis and disease management;
- Translational and clinical studies on emerging therapies.
This Special Issue welcomes contributions from diverse disciplines, including neuroscience, ophthalmology, molecular biology, pharmacology, and biomedical engineering. By bridging these fields, this issue aims to advance our understanding and treatment of complex retinal and neurodegenerative diseases.
Dr. Tonking Bastola
Dr. Won-Kyu Ju
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glaucoma
- Alzheimer's diseases
- retinal disease
- neuroprotection
- neuroinflammation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
